By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Navidea Biopharmaceuticals 

425 Metro Place Northurt
Suite 400
Dublin  Ohio  43017  U.S.A.
Phone: 614-793-7500 Fax: 614 793 7520


Medical Device

Company News
Navidea Biopharmaceuticals (NAVB) Announces Scientific Presentations Of Results From Lymphoseek® Studies At The European Association Of Nuclear Medicine And European Society Of Surgical Oncology Meetings 10/30/2014 10:08:10 AM
Navidea Biopharmaceuticals (NAVB) To Announce Third Quarter 2014 Financial Results On November 6, 2014 10/29/2014 9:08:20 AM
FDA Approves Expanded Use Of Navidea Biopharmaceuticals (NAVB)’s Lymphoseek® For Lymphatic Mapping In Solid Tumors 10/15/2014 10:59:40 AM
Navidea Biopharmaceuticals (NAVB) Brings In A New CEO 10/15/2014 6:47:34 AM
Navidea Biopharmaceuticals (NAVB) To Participate In The BTIG Emerging Technologies In Healthcare Diagnostics Investor Conference September 30th 9/30/2014 9:42:25 AM
Navidea Biopharmaceuticals (NAVB)’s Lymphoseek® Recommended By CHMP For European Approval In Sentinel Lymph Node Detection For Melanoma, Breast And Certain Head And Neck Cancers 9/26/2014 8:15:55 AM
Navidea Biopharmaceuticals (NAVB) Awarded $1.67M Fast Track National Institutes of Health (NIH) SBIR Grant For Evaluation Of Lymphoseekв In Cervical Cancer 9/23/2014 11:28:01 AM
Navidea Biopharmaceuticals (NAVB) Receives Orphan Drug Designation From FDA For Use Of Lymphoseek® In Head And Neck Cancers 9/19/2014 11:01:53 AM
Hainan Sinotau In-Licenses Radiopharmaceutical From Navidea Biopharmaceuticals (NAVB) Of The U.S. 9/5/2014 11:33:00 AM
Navidea Biopharmaceuticals (NAVB) Enters Lymphoseek® Development And Commercialization Agreement For China 9/4/2014 11:31:32 AM